Aaron Royston
InvestorManaging Partner at venBio Partners · Board director at Rayze Bio · Board director at Ventyx Biosciences · Board director at Harmony Biosciences
San Francisco Bay Area
Writes $20M – $30M checks · typically $25M
About
Aaron Royston, an MD and Wharton MBA with clinical research experience, was recognized as a White House Champion of Change and helped found and guide RayzeBio to IPO and acquisition.
Invests in
BiotechHealthtech
Board director at Rayze Bio
Intro paths
In turn, Aaron can intro founders to Rayze Bio's investors below.
Rayze Bio's investors · 8
Co-founders at Rayze Bio
Board director at Ventyx Biosciences
Intro paths
In turn, Aaron can intro founders to Ventyx Biosciences's investors below.
Board director at Harmony Biosciences
Intro paths
In turn, Aaron can intro founders to Harmony Biosciences's investors below.
Harmony Biosciences's investors · 5
Co-founders at Harmony Biosciences
Experience
- venBio PartnersManaging Partnercurrent2015 — presentSan Francisco Bay Area
- Achieve Life SciencesBoard of Directorscurrent2026 — presentSan Francisco, California, United States
- Caldera TherapeuticsBoard of Directorscurrent2025 — presentBoston, Massachusetts, United States
- Marrow TherapeuticsBoard of Directorscurrent2024 — presentBoston, Massachusetts, United States
- Attovia TherapeuticsBoard of Directorscurrent2023 — presentSan Francisco Bay Area
- Candid TherapeuticsBoard of Directors2024 — 2026San Diego, California, United States
- 35PharmaBoard of Directors2022 — 2026Montreal, Quebec, Canada
- VicebioBoard of Directors2024 — 2025London Area, United Kingdom
- Ablaze PharmaceuticalsBoard of Directors2021 — 2025Shanghai, China
- RayzeBioBoard of Directors2020 — 2023San Diego, California, United States
- Ventyx BiosciencesBoard of Directors2021 — 2023San Diego, California, United States
- Harmony BiosciencesBoard Of Directors2017 — 2020Greater Philadelphia
- Akero TherapeuticsBoard Of Directors2018 — 2019San Francisco Bay Area
- Menlo Therapeutics Inc.Board Of Directors2017 — 2019San Francisco Bay Area
- Apellis PharmaceuticalsBoard of Directors2015 — 2017Louisville, Kentucky, United States
- Vivo CapitalSenior Associate2014 — 2015Palo Alto, CA
- Bain & CompanyConsultant2013 — 2014San Francisco Bay Area
- SportaneousFounder2010 — 2012
- The Mount Sinai HospitalClinical Research Coordinator2007 — 2008New York City
Skills & more
+4 more
Start-upsLife SciencesVenture CapitalStrategic PlanningFrom Aaron's professional profile.
Deals · 6
Marea Therapeutics, Inc.Board seat
via venBio Partners · filed Jun 2024 · $160.4M raise
Rayze BioBoard seat
via venBio Partners · filed Nov 2020 · $45M raise
Harmony BiosciencesBoard seat
via venBio Partners · filed Aug 2019 · $50M raise
Akero Therapeutics, Inc.Board seat
via venBio Partners · filed Dec 2018 · $45.5M raise
Menlo TherapeuticsBoard seat
via venBio Partners · filed Jul 2017 · $50.5M raise
Impel NeuropharmaBoard seat
via venBio Partners · filed Dec 2016 · $37.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
35PharmaAblaze PharmaceuticalsAkeroApellis PharmaceuticalsAttovia TherapeuticsCandid TherapeuticsMarrow TherapeuticsVentyx BiosciencesVicebio
Sources: the firm's website · SEC Form D filings.
Colleagues at venBio Partners
Network4
Investors connected to Aaron in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Aaron Royston?
- Aaron Royston, an MD and Wharton MBA with clinical research experience, was recognized as a White House Champion of Change and helped found and guide RayzeBio to IPO and acquisition.
- Where does Aaron Royston work?
- Aaron Royston is Managing Partner at venBio Partners and Board director at Rayze Bio and Board director at Ventyx Biosciences and Board director at Harmony Biosciences.
- What does Aaron Royston invest in?
- Aaron Royston invests in Biotech, Healthtech.
- What check size does Aaron Royston write?
- Aaron Royston typically writes checks of $20M – $30M.
- What boards does Aaron Royston sit on?
- Aaron Royston holds tracked board seats at 35Pharma, Ablaze Pharmaceuticals, Akero, Akero Therapeutics, Inc., Apellis Pharmaceuticals, Attovia Therapeutics, Candid Therapeutics, Harmony Biosciences, Harmony Biosciences, Impel Neuropharma.
- Where did Aaron Royston go to school?
- Aaron Royston studied at The Wharton School (Master of Business Administration (M.B.A.), Health/Health Care Administration/Management); University of Pennsylvania (Doctor of Medicine (M.D.)); Duke University (B.S., Biological Sciences).
Same school
Also attended The Wharton School1,559
+ 1,553 more
Also attended University of Pennsylvania827
+ 821 more
Also attended Duke University522
+ 516 more
